Keywords: merck, seek, vioxx, ok, rheumatoid, arthritis, genzyme

Merck to seek Vioxx OK for rheumatoid arthritis

Article | 24 November 2000

Genzyme General and BioMarin Pharmaceutical are initiating Phase IIIclinical development of their recombinant alpha-L-iduronidase enzyme replacement therapy, Aldurazyme (laronidase), for ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Genzyme

Go to company listing

Related Drugs

Aldurazyme

Laronidase

Alpha

Prolastin

Antihemophilic Factor

Go to drug listing